Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$112.00

3.41 (3.14%)

12:25
10/04/18
10/04
12:25
10/04/18
12:25

Eli Lilly to hold a conference call

Management discusses the Company's Phase 2b Study of LY3298176, a GIP and GLP-1 dual receptor agonist, recently presented at the EASD 54th Annual Meeting, on a conference call to be held on October 4 at 1 pm. Webcast Link

  • 04

    Oct

  • 19

    Oct

  • 06

    Nov

LLY Eli Lilly
$112.00

3.41 (3.14%)

10/04/18
DBAB
10/04/18
NO CHANGE
DBAB
Buy
Novo Nordisk pullback on Lilly data likely overdone, says Deutsche Bank
Deutsche Bank analyst Tim Race noted that Novo Nordisk (NVO) shares have reacted to "strong" diabetes trial data from competitor Eli Lilly (LLY), but at first glance he thinks the move seems overdone. While a potential meaningful competitor creates a new overhang, the risk needs to be placed in to context, said the analyst, who noted the Phase 2 data will need to be confirmed in extensive Phase 3 trials before it is able to impact Novo's growth prospects. From what he understands, Phase 3 trials would commence in 2019, suggesting a potential 2023 launch of Lilly's LY3298176, which should give Novo time to adjust and react, Race tells investors. He maintains a Buy rating on Novo Nordisk shares.
10/03/18
BMOC
10/03/18
NO CHANGE
Target $107
BMOC
Market Perform
Eli Lilly price target raised to $107 from $90 at BMO Capital
BMO Capital analyst Alex Arfaei raised his price target on Eli Lilly to $107 to reflect the recent run-up in the stock price, though he says he would not recommend "chasing it" at current price level. The analyst cites the company's "solid commercial execution" and unlocked value of Elanco divestiture, adding that its upcoming LY'176 data at EASD should strengthen its long-term growth prospects in the GLP-1 market. Arfaei keeps his Market Perform rating on Eli Lilly, adding that the stock looks "fairly valued" with underappreciated risks around insulins and opportunities around (Tanezumab, GIP/GLP-1, migraine and Alzheimer's franchises.
10/01/18
RHCO
10/01/18
NO CHANGE
Target $123
RHCO
Buy
Eli Lilly price target raised to $123 from $105 at SunTrust
SunTrust analyst John Boris raised his price target on Eli Lilly to $123 after meeting with its management and investors, saying the discussions highlighted the company's "solid execution" and diversified volume-driven pipeline growth. The analyst cites the company's "new indications or line extension" - NILEX - opportunities, pointing to diabetes gains from Trulicity, immunology label expansion for Taltz, and another leg of growth in its pain drugs. Boris keeps his Buy rating on Eli Lilly and believes that it is "positioned to drive earnings growth faster than sales, as gross margin and fixed cost leverage yield operating margin expansion".
10/01/18
GSCO
10/01/18
UPGRADE
Target $30
GSCO
Conviction Buy
Teva upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Jami Rubin added Teva Pharmaceuticals (TEVA) to Goldman's Conviction List with a Buy rating. The analyst calls the recent selloff in the shares a "head scratcher" and sees a buying opportunity at current levels. Recent concerns raised in the marketplace regarding second half of 2018 headwinds and Eli Lilly's (LLY) galcenuzemab approval were already expected and well understood, Rubin tells investors in a research note. The analyst sees "meaningful upside" in shares of Teva and has a $30 price target for the name.

TODAY'S FREE FLY STORIES

S

Sprint

$6.80

-0.155 (-2.23%)

16:50
08/20/19
08/20
16:50
08/20/19
16:50
Options
Sprint put spread is largest block on lightest volume day of the month »

Sprint put spread is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

CAH

Cardinal Health

$43.74

0.26 (0.60%)

16:49
08/20/19
08/20
16:49
08/20/19
16:49
Syndicate
Breaking Syndicate news story on Cardinal Health »

Cardinal Health files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

DIS

Disney

$135.08

-0.25 (-0.18%)

, SNE

Sony

$55.69

-0.02 (-0.04%)

16:46
08/20/19
08/20
16:46
08/20/19
16:46
Periodicals
Disney-Sony dispute ends Feige's involvement with 'Spider-Man,' Deadline says »

Marvel Studios president…

DIS

Disney

$135.08

-0.25 (-0.18%)

SNE

Sony

$55.69

-0.02 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMCR

Amcor

$9.99

-0.12 (-1.19%)

16:45
08/20/19
08/20
16:45
08/20/19
16:45
Earnings
Amcor sees FY20 adjusted constant currency EPS growth of approximately 5%-10% »

For the 2020 fiscal year,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

AIG

AIG

$53.38

-1.42 (-2.59%)

16:44
08/20/19
08/20
16:44
08/20/19
16:44
Hot Stocks
AIG names Sabra Purtill as Deputy CFO, Head of Treasury »

American International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 18

    Sep

AMCR

Amcor

$9.99

-0.12 (-1.19%)

16:41
08/20/19
08/20
16:41
08/20/19
16:41
Hot Stocks
Amcor declares quarterly dividend of 12c per share »

The Amcor Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

KLAC

KLA-Tencor

$140.38

-0.06 (-0.04%)

16:41
08/20/19
08/20
16:41
08/20/19
16:41
Hot Stocks
KLA-Tencor officer Amichai Steimberg sells over $1.2M in company shares »

KLA-Tencor officer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

AMCR

Amcor

$9.99

-0.12 (-1.19%)

16:39
08/20/19
08/20
16:39
08/20/19
16:39
Hot Stocks
Amcor approves $500M share buyback »

Amcor CEO Ron Delia said:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

16:38
08/20/19
08/20
16:38
08/20/19
16:38
General News
API crude inventories for week of August 16 »

API reports that crude…

JKHY

Jack Henry

$140.79

-0.72 (-0.51%)

16:36
08/20/19
08/20
16:36
08/20/19
16:36
Earnings
Jack Henry & Associates reports Q4 EPS 79c, consensus 77c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 11

    Sep

  • 12

    Sep

CECO

Career Education

$21.94

-0.05 (-0.23%)

16:35
08/20/19
08/20
16:35
08/20/19
16:35
Hot Stocks
Career Education VP Michele Peppers sells over $221K in company shares »

Career Education VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 25

    Sep

  • 26

    Sep

ALC

Alcon

$62.45

0.66 (1.07%)

16:35
08/20/19
08/20
16:35
08/20/19
16:35
Earnings
Breaking Earnings news story on Alcon »

Alcon sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 04

    Sep

  • 09

    Sep

NDSN

Nordson

$135.43

-1.79 (-1.30%)

16:34
08/20/19
08/20
16:34
08/20/19
16:34
Hot Stocks
Nordson expects flat to modest organic sales growth in FY19 »

Expects an unfavorable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

HD

Home Depot

$217.14

9.165 (4.41%)

, KSS

Kohl's

$44.87

-3.33 (-6.91%)

16:34
08/20/19
08/20
16:34
08/20/19
16:34
On The Fly
Fly Intel: Wall Street's top stories for Tuesday »

The S&P 500 halted a…

HD

Home Depot

$217.14

9.165 (4.41%)

KSS

Kohl's

$44.87

-3.33 (-6.91%)

TJX

TJX

$51.55

(0.00%)

ELAN

Elanco

$27.25

-2.57 (-8.62%)

BAYRY

Bayer

$0.00

(0.00%)

SABR

Sabre

$23.73

-0.2 (-0.84%)

FB

Facebook

$183.76

-2.46 (-1.32%)

ENDP

Endo

$3.02

0.47 (18.43%)

MDT

Medtronic

$106.91

2.76 (2.65%)

SRPT

Sarepta

$101.90

-18.26 (-15.20%)

FN

Fabrinet

$46.40

-10 (-17.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 20

    Aug

  • 21

    Aug

  • 22

    Aug

  • 04

    Sep

  • 09

    Sep

  • 11

    Sep

  • 15

    Sep

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Oct

NDSN

Nordson

$135.43

-1.79 (-1.30%)

16:33
08/20/19
08/20
16:33
08/20/19
16:33
Hot Stocks
Breaking Hot Stocks news story on Nordson »

Nordson reports FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

TOL

Toll Brothers

$36.91

0.52 (1.43%)

16:33
08/20/19
08/20
16:33
08/20/19
16:33
Earnings
Toll Brothers sees FY19 deliveries 7,800-8,100 units »

The company expects FY…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

ALC

Alcon

$62.45

0.66 (1.07%)

16:33
08/20/19
08/20
16:33
08/20/19
16:33
Earnings
Alcon reports Q2 core EPS 47c, consensus 48c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 04

    Sep

  • 09

    Sep

ORLY

O'Reilly Automotive

$383.21

-2.42 (-0.63%)

16:33
08/20/19
08/20
16:33
08/20/19
16:33
Hot Stocks
O'Reilly Automotive to acquire Mayasa Auto Parts, terms not disclosed »

O'Reilly Automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$135.43

-1.79 (-1.30%)

16:33
08/20/19
08/20
16:33
08/20/19
16:33
Earnings
Nordson reports Q3 GAAP EPS $1.62, consensus $1.81 »

Reports Q3 revenue $560M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

TOL

Toll Brothers

$36.91

0.52 (1.43%)

16:32
08/20/19
08/20
16:32
08/20/19
16:32
Earnings
Toll Brothers reports Q3 EPS $1.00, consensus 82c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

16:30
08/20/19
08/20
16:30
08/20/19
16:30
Options
Preliminary option volume of 15.2M today »

Preliminary option volume…

SCSG

SouthCrest Financial Group

$0.00

(0.00%)

16:28
08/20/19
08/20
16:28
08/20/19
16:28
Hot Stocks
SouthCrest Financial Group announces $5M share repurchase pact »

SouthCrest Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BP

BP

$36.44

-0.42 (-1.14%)

16:25
08/20/19
08/20
16:25
08/20/19
16:25
Initiation
BP initiated  »

BP initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 25

    Sep

ABBV

AbbVie

$66.38

-0.17 (-0.26%)

16:23
08/20/19
08/20
16:23
08/20/19
16:23
Hot Stocks
AbbVie VP Jeffrey Stewart buys over $1M in company shares »

AbbVie VP Jeffrey Stewart…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

CREE

Cree

$58.19

-0.09 (-0.15%)

16:20
08/20/19
08/20
16:20
08/20/19
16:20
Hot Stocks
Breaking Hot Stocks news story on Cree »

Cree down 7.5% after Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.